• Users Online: 558
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
LETTER TO EDITOR
Year : 2020  |  Volume : 15  |  Issue : 2  |  Page : 333

Thrombocytopenia among patients with novel wuhan coronavirus infection: An observation on 42 cases in the 1st month of outbreak


1 KMT Primary Care Center, Bangkok, Thailand
2 Dr. DY Patil University, Pune, Maharashtra, India; Hainan Medical University, Haikou, China

Date of Submission28-Jan-2020
Date of Decision18-Feb-2020
Date of Acceptance30-Mar-2020
Date of Web Publication21-Dec-2020

Correspondence Address:
Dr. Sora Yasri
KMT Primary Care Center, Bangkok
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jdmimsu.jdmimsu_27_20

Rights and Permissions

How to cite this article:
Yasri S, Wiwanitkit V. Thrombocytopenia among patients with novel wuhan coronavirus infection: An observation on 42 cases in the 1st month of outbreak. J Datta Meghe Inst Med Sci Univ 2020;15:333

How to cite this URL:
Yasri S, Wiwanitkit V. Thrombocytopenia among patients with novel wuhan coronavirus infection: An observation on 42 cases in the 1st month of outbreak. J Datta Meghe Inst Med Sci Univ [serial online] 2020 [cited 2021 Jan 20];15:333. Available from: http://www.journaldmims.com/text.asp?2020/15/2/333/304255



Dear Editor,

In December 2019, a new emerging infectious disease, Wuhan novel coronavirus infection, was reported from China.[1] The patients usually have fever and pneumonia.[1] At present, this emerging disease already exists outside China, and the infection is presently a new public health concern worldwide.[2] Regarding the new coronavirus infection, an important consideration in clinical hematology is the hematological alteration due to infection. In Middle East respiratory syndrome (MERS), a recent emerging coronavirus infection, thrombocytopenia is a common clinical finding.[3] Here, the authors assessed on the available data on 42 infected cases during the 1st month of outbreak, in China and Thailand,[1],[2] to find out the magnitude of thrombocytopenia. Of interest, no patient has presented with thrombocytopenia. Unlike MERS, the novel Wuhan coronavirus infection has no clinical association with thrombocytopenia.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Hsia W. Emerging new coronavirus infection in Wuhan, China: Situation in early 2020. Case Study Case Rep 2020;10:8-9.  Back to cited text no. 1
    
2.
Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Adv Trop Med Pub Health Int 2019;9:1-2.  Back to cited text no. 2
    
3.
Joob B, Wiwanitkit V. Magnitude to thrombocytopenia among the patients with novel Middle East respiratory syndrome. Platelets 2015;26:612.  Back to cited text no. 3
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References

 Article Access Statistics
    Viewed144    
    Printed10    
    Emailed0    
    PDF Downloaded19    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]